FLGT Q1 2023 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q1 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$66M-79.3% YoY

Gross Profit

$19M28.4% margin

Operating Income

-$25M-37.5% margin

Net Income

-$15M-23.2% margin

EPS (Diluted)

$-0.52

QoQ Revenue Growth

-2.3%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$10M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$108M

Stockholders' Equity

$1.3B

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66M	$320M	-79.3%
Gross Profit	$19M	$243M	-92.2%
Operating Income	-$25M	$202M	-112.3%
Net Income	-$15M	$154M	-110.0%

Geographic Segments

UNITED STATES

$62M94%

Non-US

$4M6%